Creative Edge Nutrition will not recover from the
Post# of 56323
February 22, 2015: In an unprecedented move destined to protect the investing public from an investment scam, the Canadian government, through its Department of National Health, issued a statement on Friday stating that CEN Biotech's update to shareholders of Creative Edge Nutrition, Inc. (FITX), "mischaracterizes the meaning of the Department’s recent action in respect of the application for a license to produce under the Marihuana for Medical Purposes Regulations (MMPR)."
Health Canada rightly felt it necessary to make clear the nature of its letter to the FITX subsidiary after the company released the misleading update. "On February 13, 2015, Health Canada sent a 'Notice of Intent to Refuse' to CEN Biotech in response to the license application. The MMPR requires that Health Canada give notice to any applicant to whom it intends to refuse a licence. The applicant is provided 20 days to provide written representations."
Last week, we relayed a report that Health Canada had informed the company of its intention through a letter. In an obvious attempt to create false hope for its investors and coerce more pigeons to feed on its stock, FITX attempted to pooh-pooh that letter by stating that the government was merely requesting more information from the company. The Health Canada statement clearly accuses FITX of lying.
No matter where you stand on FITX's attempt to gain a license, one thing is perfectly clear, and that is that Health Canada's accusations of fibbing are dead on. There is just no other way to characterize Thursday's press release from the company. It is not the first time FITX has lied, as we pointed out in this report and is a clear testament to Bill Chaaban's anything-to-get-rich priorities. It is also one of several events that has rightly caused concern that FITX's intentions are anything but honorable. The company certainly didn't ingratiate itself to Health Canada when it suggested that the agency had improperly provided advance information to Canada's national newspaper, The Globe and Mail. It would have been difficult for a government agency to grant a license for production of a controlled substance to an entity that cannot be considered trustworthy.
http://www.pumpsanddumps.com/2015/02/its-offi...nment.html